A new editorial published in JAMA Oncology warns that cancer care progress is under threat from a "trifecta" of challenges: proposed federal budget cuts, a surge in medical misinformation, and a critical gap in public health literacy.

A research group led by Professor Cecilia Sahlgren at Åbo Akademi University in Finland and the InFLAMES Research Flagship has identified a new mechanism directing the adverse remodeling of tumor tissue during breast cancer progression. This discovery could offer new treatment opportunities against aggressive forms of breast cancer which currently lack targeted therapy options.

New combination treatment benefits patients with leptomeningeal metastases from breast cancer

A dual targeting approach improves immunotherapy responses in glioblastoma

Low testosterone levels associated with increased risk of prostate cancer progression

New biomarker predicts chemotherapy response in triple-negative breast cancer